Table 3 Socioeconomic gradients in risk ratios for amenable mortality by income and cause of death, women aged 25-74

All cause mortality

5

1.00

1.00

1.00

PI vs PII

<.001

4

1.27

(1.09 - 1.47 )

1.28

(1.10 - 1.48 )

1.29

(1.12 - 1.49 )

PII vs PIII

0.12

3

1.52

(1.34 - 1.73 )

1.55

(1.36 - 1.76 )

1.54

(1.34 - 1.77 )

PI vs PIII

<.001

2

1.82

(1.60 - 2.06 )

1.98

(1.74 - 2.25 )

2.00

(1.70 - 2.35 )

1

2.53

(2.24 - 2.86 )

2.98

(2.63 - 3.38 )

3.26

(2.68 - 3.96 )

Total disease mortality

5

1.00

1.00

1.00

PI vs PII

<.001

4

1.29

(1.11 - 1.50 )

1.29

(1.11 - 1.49 )

1.30

(1.14 - 1.48 )

PII vs PIII

0.24

3

1.53

(1.34 - 1.74 )

1.55

(1.37 - 1.75 )

1.53

(1.34 - 1.75 )

PI vs PIII

<.001

2

1.80

(1.58 - 2.05 )

1.93

(1.71 - 2.18 )

1.95

(1.67 - 2.27 )

1

2.47

(2.18 - 2.81 )

2.91

(2.58 - 3.28 )

3.12

(2.58 - 3.76 )

Total amenable mortality

5

1.00

1.00

1.00

PI vs PII

<.001

4

1.19

(1.04 - 1.38 )

1.19

(1.04 - 1.38 )

1.24

(1.12 - 1.38 )

PII vs PIII

0.05

3

1.37

(1.22 - 1.55 )

1.43

(1.25 - 1.64 )

1.47

(1.31 - 1.65 )

PI vs PIII

<.001

2

1.52

(1.34 - 1.72 )

1.62

(1.42 - 1.85 )

1.77

(1.56 - 2.01 )

1

2.22

(1.97 - 2.51 )

2.57

(2.26 - 2.92 )

2.93

(2.53 - 3.40 )

Early detection and intervention

5

1.00

1.00

1.00

PI vs PII

0.04

4

1.17

(1.04 - 1.32 )

1.19

(1.06- 1.35 )

1.20

(1.08 - 1.34 )

PII vs PIII

0.17

3

1.33

(1.20 - 1.46 )

1.39

(1.23 - 1.57 )

1.38

(1.23 - 1.55 )

PI vs PIII

<.001

2

1.40

(1.27- 1.54)

1.49

(1.32 - 1.67 )

1.58

(1.41 - 1.76 )

1

1.80

(1.63 - 1.99 )

1.99

(1.73- 2.29 )

2.19

(1.93 - 2.48 )

- malignant neoplasm

5

1.00

*

1.00

1.00

PI vs PII

0.01

4

1.11

(0.96 - 1.29 )

1.19

(1.01 - 1.40 )

1.13

(0.96 - 1.32 )

PII vs PIII

<.001

3

1.23

(1.08 - 1.39 )

1.40

(1.98 - 1.65 )

1.31

(1.09 - 1.56 )

PI vs PIII

<.001

2

1.10

(0.96 - 1.26 )

1.28

(1.08 - 1.52 )

1.37

(1.14 - 1.63 )

1

1.06

(0.91 - 1.24 )

1.29

(1.10 - 1.52 )

1.57

(1.31 - 1.87 )

- hypertension and cerebrovascular disease

5

1.00

1.00

1.00

PI vs PII

0.11

4

1.29

(1.07 - 1.57 )

1.23

(1.01 - 1.51 )

1.49

(1.32 - 1.66 )

PII vs PIII

0.21

3

1.55

(1.31 - 1.82 )

1.46

(1.26 - 1.71 )

1.74

(1.57 - 1.94 )

PI vs PIII

0.01

2

1.87

(1.62 - 2.15 )

1.92

(1.69 - 2.18 )

2.26

(2.01 - 2.53 )

1

2.83

(2.46 - 3.26 )

3.16

(2.72 - 3.66 )

3.75

(3.15 - 4.45 )

Improved treatment and medical care

5

1.00

1.00

1.00

PI vs PII

<.001

4

1.35

(0.91 - 2.01 )

1.14

(0.73 - 1.77 )

1.71

(1.11 - 2.64 )

PII vs PIII

<.001

3

1.71

(1.17 - 2.49 )

1.73

(1.15 - 2.61 )

2.46

(1.82 - 3.31 )

PI vs PIII

<.001

2

2.41

(1.66 - 3.51 )

2.60

(1.76 - 3.83 )

4.02

(2.90 - 5.56 )

1

5.44

(3.79 - 7.81 )

6.70

(4.55 - 9.88 )

11.41

(8.15 - 16.0 )

- predominantly primary care

5

1.00

1.00

1.00

PI vs PII

0.41

4

1.20

(0.69 - 2.07 )

1.52

(0.91 - 2.55 )

2.14

(1.08 - 4.23 )

PII vs PIII

<.001

3

1.56

(0.89 - 2.73 )

1.99

(1.17 - 3.38 )

3.43

(1.79 - 6.57 )

PI vs PIII

<.001

2

2.85

(1.60 - 5.07 )

3.55

(2.18 - 5.80 )

8.42

(4.33 - 16.4 )

1

4.55

(2.79 - 7.42 )

6.01

(3.88 - 9.33 )

20.54

(11.4 - 36.8 )

- predominantly specialist care

5

1.00

1.00

1.00

PI vs PII

0.01

4

1.40

(0.90 - 2.18 )

1.06

(0.65 - 1.73 )

1.66

(1.05 - 2.62 )

PII vs PIII

0.06

3

1.74

(1.14 - 2.66 )

1.70

(1.07 - 2.71 )

2.32

(1.70 - 3.17 )

PI vs PIII

<.001

2

2.37

(1.55 - 3.62 )

2.51

(1.64 - 3.81 )

3.58

(2.56 - 5.02 )

1

5.62

(3.72 - 8.49 )

6.90

(4.50 – 10.6 )

10.36

(7.14 - 15.0 )

Ischaemic heart disease

5

1.00

1.00

1.00

PI vs PII

<.001

4

1.40

(1.24-1.58)

1.49

(1.30-1.70)

1.57

(1.39-1.78)

PII vs PIII

<.001

3

1.71

(1.54-1.90)

1.91

(1.67-2.18)

2.01

(1.77-2.29)

PI vs PIII

<.001

2

2.15

(1.92-2.40)

2.51

(2.18-2.90)

2.81

(2.43-3.25)

1

2.51

(2.27-2.80)

2.97

(2.61-3.39)

4.01

(3.51-4.59)